Reciprocal communication between different cell types contributes to neuronal integrity

Published on July 16, 2013 at 11:25 AM · No Comments

Glial cells send 'care packages' including protective proteins and genetic information to nerve cells

Researchers at Johannes Gutenberg University Mainz (JGU) have discovered a new form of communication between different cell types in the brain. Nerve cells interact with neighboring glial cells, which results in a transfer of protein and genetic information. Nerve cells are thus protected against stressful growth conditions. The study undertaken by the Mainz-based cell biologists shows how reciprocal communication between the different cell types contributes to neuronal integrity. Their results have been recently published in the journal PLOS Biology.

Brain function is determined by the communication between electrically excitable neurons and the surrounding glial cells, which perform many tasks in the brain. Oligodendrocytes are a type of glial cell and these form an insulating myelin sheath around the axons of neurons. In addition to providing this protective insulation, oligodendrocytes also help sustain neurons in other ways that are not yet fully understood. If this support becomes unavailable, axons can die off. This is what happens in many forms of myelin disorders, such as multiple sclerosis, and it results in a permanent loss of neuron impulse transmission.

Like other types of cell, oligodendrocytes also secrete small vesicles. In addition to lipids and proteins, these membrane-enclosed transport packages also contain ribonucleic acids, in other words, genetic information. In their study, Carsten Fr-hbeis, Dominik Fr-hlich, and Wen Ping Kuo of the Institute of Molecular Cell Biology at Johannes Gutenberg University Mainz found that oligodendrocytes release nano-vesicles known as 'exosomes' in response to neuronal signals. These exosomes are taken up by the neurons and their cargo can then be used for neuronal metabolism. "This works on a kind of 'delivery on call' principle," explained Dr. Eva-Maria Kr-mer-Albers, who is leading the current study. "We believe that what are being delivered are 'care packages' that are sent by the oligodendrocytes to neurons."

While studying cell cultures, the research group discovered that the release of exosomes is triggered by the neurotransmitter glutamate. By means of labeling them with reporter enzymes, the researchers were able to elegantly demonstrate that the small vesicles are absorbed into the interior of the neurons. "The entire package of substances, including the genetic information, is apparently utilized by the neurons," said Kr-mer-Albers. If neurons are subjected to stress, cells that have been aided with 'care packages' subsequently recover. "This maintenance contributes to the protection of the neurons and probably also leads to de novo synthesis of proteins," stated Carsten Fr-hbeis and Dominik Fr-hlich. Among the substances that are present in the exosomes and are channeled to the neurons are, for instance, protective proteins such as heat shock proteins, glycolytic enzymes, and enzymes which counter oxidative stress.

The study has demonstrated that exosomes from oligodendrocytes participate in a previously unknown form of bidirectional cell communication that could play a significant role in the long-term preservation of nerve fibers. "An interaction like this, in which an entire package of substances including genetic information is exchanged between cells of the nervous system, has not previously been observed", stated Kr-mer-Albers, summarizing the results. "Exosomes are thus similar to viruses in certain respects, with the major difference that they do not inflict damage on the target cells but are instead beneficial." In the future, the researchers hope to develop exosomes as possible 'cure' packages that could be used in the treatment of nerve disorders.

Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Русский | Svenska | Polski
Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post
You might also like... ×
FDA grants Breakthrough Therapy status to Novartis' CTL019 for treatment of relapsed/refractory ALL